EIF5A2 predicts outcome in localised invasive bladder cancer and promotes bladder cancer cell aggressiveness in vitro and in vivo

British Journal of Cancer

Volumn 110, Issue 7, 2014, Pages 1767-1777

  Wei, J H ^a   Cao, J Z ^a   Zhang, D ^a   Liao, B ^a   Zhong, W M ^a   Lu, J ^a   Zhao, H W ^b   Zhang, J X ^a   Tong, Z T ^c   Fan, S ^c   Liang, C Z ^c   Liao, Y B ^a   Pang, J ^a   Wu, R H ^a   Fang, Y ^a   Chen, Z H ^a   Li, B ^a   Xie, D ^d   Chen, W ^a   Luo, J H ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b QINGDAO UNIVERSITY   (China)

^c ANHUI MEDICAL UNIVERSITY   (China)

^d SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

aggressiveness; bladder cancer; EIF5A2; epithelial mesenchymal transition; STAT3; TGF b1

Indexed keywords

EIF5A2 PROTEIN; INITIATION FACTOR 5A; STAT3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; ALPHA CATENIN; FIBRONECTIN; INITIATION FACTOR; INITIATION FACTOR 5A2; UVOMORULIN; VIMENTIN;

ADULT; ARTICLE; BLADDER CANCER; CANCER LOCALIZATION; CANCER SURGERY; CYSTECTOMY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN STABILITY; RNA INTERFERENCE; TISSUE MICROARRAY; TUMOR INVASION; WESTERN BLOTTING; ANIMAL TISSUE; CANCER CELL; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; HUMAN CELL; HUMAN TISSUE; METASTASIS FREE SURVIVAL; MOUSE; NONHUMAN; PROTEIN LOCALIZATION; UPREGULATION;

ANIMALS; CELL MOVEMENT; CELLS, CULTURED; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM INVASIVENESS; PEPTIDE INITIATION FACTORS; PROGNOSIS; RETROSPECTIVE STUDIES; RNA-BINDING PROTEINS; STAT3 TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA1; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 84897570497     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2014.52     Document Type: Article

References (30)

1. Chen W, Luo JH, Hua WF, Zhou FJ, Lin MC, Kung HF, Zeng YX, Guan XY, Xie D (2009) Overexpression of EIF-5A2 is an independent predictor of outcome in patients of urothelial carcinoma of the bladder treated with radical cystectomy. Cancer Epidemiol Biomarkers Prev 18: 400-408.
2. Eder IE, Stenzl A, Hobisch A, Cronauer MV, Bartsch G, Klocker H (1996) Transforming growth factors-beta 1 and beta 2 in serum and urine from patients with bladder carcinoma. J Urol 156: 953-957.
3. Eder IE, Stenzl A, Hobisch A, Cronauer MV, Bartsch G, Klocker H (1997) Expression of transforming growth factors beta-1, beta 2 and beta 3 in human bladder carcinomas. Br J Cancer 75: 1753-1760.
4. Eissa S, Salem AM, Zohny SF, Hegazy MG (2007) The diagnostic efficacy of urinary TGF-beta1 and VEGF in bladder cancer: comparison with voided urine cytology. Cancer Biomark 3: 275-285.
5. Guan XY, Fung JMW, Ma NF, Lau SH, Tai LS, Xie D, Zhang Y, Hu L, Wu QL, Fang Y, Sham JST (2004) Oncogenic role of eIF-5A2 in the development of ovarian cancer. Cancer Res 64: 4197-4200.
6. Guan XY, Sham JST, Tang TCM, Fang Y, Huo KK, Yang JM (2001) Isolation of a novel candidate oncogene within a frequently amplified region at 3q26 in ovarian cancer. Cancer Res 61: 3806-3809.
7. Han G, Lu SL, Li AG, He W, Corless CL, Kulesz-Martin M, Wang XJ (2005) Distinct mechanisms of TGF-beta1-mediated epithelial-to-mesenchymal transition and metastasis during skin carcinogenesis. J Clin Invest 115: 1714-1723.
8. He LR, Zhao HY, Li BK, Liu YH, Liu MZ, Guan XY, Bian XW, Zeng YX, Xie D (2011) Overexpression of eIF5A-2 is an adverse prognostic marker of survival in stage I non-small cell lung cancer patients. Int J Cancer 129: 143-150.
9. Jain S, Wei J, Mitrani LR, Bishopric NH (2012) Auto-acetylation stabilizes p300 in cardiac myocytes during acute oxidative stress, promoting STAT3 accumulation and cell survival. Breast Cancer Res Treat 135: 103-114.
10. Kim Y, Ratziu V, Choi SG, Lalazar A, Theiss G, Dang Q, Kim SJ, Friedman SL (1998) Transcriptional activation of transforming growth factor beta1 and its receptors by the Kruppel-like factor Zf9/core promoter-binding protein and Sp1. Potential mechanisms for autocrine fibrogenesis in response to injury. J Biol Chem 273: 33750-33758.
11. Lin WY, Tsai WL, Shao RX, Wu GY, Peng LF, Barlow LL, Chung WJ, Zhang LL, Zhao H, Jang JY, Chung RT (2010) Hepatitis C virus regulates transforming growth factor beta 1 production through the generation of reactive oxygen species in a nuclear factor kappa B-dependent manner. Gastroenterology 138: 2509-2518.
12. Marchet A, Mocellin S, Belluco C, Ambrosi A, DeMarchi F, Mammano E, Digito M, Leon A, D'Arrigo A, Lise M, Nitti D (2007) Gene expression profile of primary gastric cancer: towards the prediction of lymph node status. Ann Surg Oncol 14: 1058-1064.
13. Massague J (2008) TGFbeta in cancer. Cell 134: 215-230.
14. Natsuizaka M, Ohashi S, Wong GS, Ahmadi A, Kalman RA, Budo D, Klein-Szanto AJ, Herlyn M, Diehl JA, Nakagawa H (2010) Insulin-like growth factor-binding protein-3 promotes transforming growth factorbeta 1-mediated epithelial-to-mesenchymal transition and motility in transformed human esophageal cells. Carcinogenesis 31: 1344-1353.
15. Nguyen DX, Bos PD, Massague J (2009) Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer 9: 274-284.
16. Ogata H, Chinen T, Yoshida T, Kinjyo I, Takaesu G, Shiraishi H, Iida M, Kobayashi T, Yoshimura A (2006) Loss of SOCS3 in the liver promotes fibrosis by enhancing STAT3-mediated TGF-beta1 production. Oncogene 25: 2520-2530.
17. Pelucchi C, Bosetti C, Negri E, Malvezzi M, La Vecchia C (2006) Mechanisms of disease: the epidemiology of bladder cancer. Nat Clin Pract Urol 3: 327-340.
18. Qi W, Gao S, Wang ZX (2008) Transcriptional regulation of the TGF-beta 1 promoter by androgen receptor. Biochem J 416: 453-462.
19. Shariat SF, Kim JH, Andrews B, Kattan MW, Wheeler TM, Kim IY, Lerner SP, Slawin KM (2001) Preoperative plasma levels of transforming growth factor beta(1) strongly predict clinical outcome in patients with bladder carcinoma. Cancer 92: 2985-2992.
20. Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. CA Cancer J Clin 63: 11-30.
21. Stenzl A, Cowan NC, De Santis M, Kuczyk MA, Merseburger AS, Ribal MJ, Sherif A, Witjes JA. European Association of U (2011) Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines. Eur Urol 59: 1009-1018.
22. Tang DJ, Dong SS, Ma NF, Xie D, Chen LL, Fu L, Lau SH, Li Y, Li Y, Guan XY (2010) Overexpression of eukaryotic initiation factor 5A2 enhances cell motility and promotes tumor metastasis in hepatocellular carcinoma. Hepatology 51: 1255-1263.
23. Tong ZT, Cai MY, Wang XG, Kong LL, Mai SJ, Liu YH, Zhang HB, Liao YJ, Zheng F, Zhu W, Liu TH, Bian XW, Guan XY, Lin MC, Zeng MS, Zeng YX, Kung HF, Xie D (2012) EZH2 supports nasopharyngeal carcinoma cell aggressiveness by forming a co-repressor complex with HDAC1/HDAC2 and Snail to inhibit E-cadherin. Oncogene 31: 583-594.
24. Weigert C, Brodbeck K, Sawadogo M, Haring HU, Schleicher ED (2004) Upstream stimulatory factor (USF) proteins induce human TGF-beta1 gene activation via the glucose-response element-1013/-1002 in mesangial cells: up-regulation of USF activity by the hexosamine biosynthetic pathway. J Biol Chem 279: 15908-15915.
25. Wendt MK, Schiemann BJ, Parvani JG, Lee YH, Kang Y, Schiemann WP (2013) TGF-beta stimulates Pyk2 expression as part of an epithelialmesenchymal transition program required for metastatic outgrowth of breast cancer. Oncogene 32: 2005-2015.
26. Xie D, Ma NF, Pan ZZ, Wu HX, Liu YD, Wu GO, Kung HF, Guan XY (2008) Overexpression of EIF-5A2 is associated with metastasis of human colorectal carcinoma. Hum Pathol 39: 80-86.
27. Yang GF, Xie D, Liu JH, Luo JH, Li LJ, Hua WF, Wu HM, Kung HF, Zeng YX, Guan XY (2009) Expression and amplification of eIF-5A2 in human epithelial ovarian tumors and overexpression of EIF-5A2 is a new independent predictor of outcome in patients with ovarian carcinoma. Gynecol Oncol 112: 314-318.
28. Zhang HJ, Wang HY, Zhang HT, Su JM, Zhu J, Wang HB, Zhou WY, Zhang H, Zhao MC, Zhang L, Chen XF (2011) Transforming growth factor-beta 1 promotes lung adenocarcinoma invasion and metastasis by epithelial-tomesenchymal transition. Mol Cell Biochem 355: 309-314.
29. Zheng F, Liao YJ, Cai MY, Liu YH, Liu TH, Chen SP, Bian XW, Guan XY, Lin MC, Zeng YX, Kung HF, Xie D (2012) The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2. Gut 61: 278-289.
30. Zhu W, Cai MY, Tong ZT, Dong SS, Mai SJ, Liao YJ, Bian XW, Lin MC, Kung HF, Zeng YX, Guan XY, Xie D (2012) Overexpression of EIF5A2 promotes colorectal carcinoma cell aggressiveness by upregulating MTA1 through C-myc to induce epithelial-mesenchymaltransition. Gut 61: 562-575.